| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |